Loading insider details...
Latest Form 4 (Nov 3, 2026): Sale of 2,000 BBIO shares, $145.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 2,000 | $145.7K |
| Aug 18, 2026 | BridgeBio Pharma, Inc. (BBIO) | Tax Withholding | 4,714 | $376.5K |
| Aug 3, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 2,000 | $160.1K |
| May 19, 2026 | BridgeBio Pharma, Inc. (BBIO) | Tax Withholding | 4,714 | $311.7K |
| May 4, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 2,000 | $143.2K |
| Mar 20, 2026 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 14,170 | n/a |
| Feb 27, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 2,000 | $132.0K |
| Feb 18, 2026 | BridgeBio Pharma, Inc. (BBIO) | Tax Withholding | 4,349 | $327.3K |
| Dec 16, 2025 | BridgeBio Pharma, Inc. (BBIO) | Tax Withholding | 2,003 | $150.5K |
| Dec 10, 2025 | BridgeBio Pharma, Inc. (BBIO) | Sale | 2,000 | $148.5K |